...
首页> 外文期刊>Scandinavian journal of urology and nephrology >Hemorheological and hemodynamic changes in predialysis patients after normalization of hemoglobin with epoetin-alpha.
【24h】

Hemorheological and hemodynamic changes in predialysis patients after normalization of hemoglobin with epoetin-alpha.

机译:依泊汀-α使血红蛋白正常化后,透析前患者的血液流变学和血液动力学变化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Changes in blood viscosity and total peripheral resistance may contribute to increased blood pressure during partial correction of renal anemia with erythropoietin. An increase in hemoglobin level is followed by decreases in cardiac output and left ventricular mass. We examined how normalization of hemoglobin in predialysis patients affects both hemorheological and hemodynamic variables. MATERIAL AND METHODS: Twelve moderately anemic predialysis patients (hemoglobin 115.9+/-7.8 g/l) received epoetin-alpha with the aim of achieving a normal hemoglobin level (135-160 g/l). Hemorheological variables were measured using rotational viscometry. Cardiac index was determined by means of Doppler echocardiography. RESULTS: After 48 weeks, the hematocrit level had increased from 37.9%+/-3.0% to 47.0%+/-3.1% (p<0.0001). Blood viscosity increased from 3.84+/-0.33 to 4.59+/-0.4 mPa x s (p<0.001). Blood viscosity standardized to a hematocrit level of 45% and a plasma viscosity of 1.31 mPa x s did not change. Plasma viscosity, erythrocyte aggregation tendency and erythrocyte fluidity remained unchanged. The cardiac index decreased from 2.64+/-0.57 to 2.19+/-0.72 l/min/m(2) (p<0.05). The total peripheral resistance index increased from 3270+/-985 to 4013+/-1046 (dyn x s/cm(5))m(2) (p<0.05). Blood pressure remained constant, but the amount of antihypertensive medication used increased by 30%. CONCLUSIONS: Hemoglobin normalization in predialysis patients raised blood viscosity and total peripheral resistance due to an increase in hematocrit level, without other consistent hemorheological changes. Antihypertensive therapy had to be increased in many patients to maintain an acceptable blood pressure. The cardiac index was reduced, which may have prevented further development of left ventricular hypertrophy.
机译:目的:在用促红细胞生成素部分纠正肾性贫血的过程中,血液粘度和总外周阻力的变化可能导致血压升高。血红蛋白水平升高后,心输出量和左心室质量降低。我们检查了透析前患者血红蛋白的正常化如何影响血液流变学和血液动力学变量。材料与方法:12名中度贫血的透析前患者(血红蛋白115.9 +/- 7.8 g / l)接受依泊汀-α治疗,以达到正常的血红蛋白水平(135-160 g / l)。使用旋转粘度计测量血液流变学变量。心脏指数通过多普勒超声心动图确定。结果:48周后,血细胞比容水平从37.9%+ /-3.0%增加到47.0%+ /-3.1%(p <0.0001)。血液粘度从3.84 +/- 0.33增加到4.59 +/- 0.4 mPa x s(p <0.001)。标准化为血细胞比容水平为45%的血液粘度和血浆粘度为1.31 mPa x s不变。血浆粘度,红细胞聚集趋势和红细胞流动性保持不变。心脏指数从2.64 +/- 0.57降至2.19 +/- 0.72 l / min / m(2)(p <0.05)。总外周电阻指数从3270 +/- 985增加到4013 +/- 1046(dyn x s / cm(5))m(2)(p <0.05)。血压保持恒定,但是降压药的使用量增加了30%。结论:由于血细胞比容水平的增加,透析前患者的血红蛋白正常化可提高血液粘度和总外周阻力,而无其他持续的血液流变学改变。许多患者必须增加抗高血压治疗以维持可接受的血压。心脏指数降低,这可能阻止了左心室肥大的进一步发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号